Catalyst
Slingshot members are tracking this event:
Amicus (FOLD) to Meet with FDA in Q2 to Discuss Regulatory Path for Migalastat in Treatment of Fabry Disease
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| FOLD |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 30, 2016
Occurred Source:
http://ir.amicusrx.com/releasedetail.cfm?ReleaseID=984007
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Migalastat, Regulatory Path, Fda, Fabry Disease, Q2, Transmembrane Conductance Regulator
